JOHNSON & JOHNSON ORDERED TO PAY $72M IN TALCUM POWDER OVARIAN CANCER CASE

Feb 24, 2016

By Jane Brown

Share on

In a landmark case in the U.S., Johnson & Johnson has been ordered to pay $72 million to the family of a woman who died of ovarian cancer.

Jacqueline Fox’s disease was linked to her use of the company’s talc-based Baby Powder and Shower to Shower for several decades.

Johnson & Johnson faces several hundred lawsuits claiming that it failed for decades to warn consumers that its talc-based products could cause cancer. This verdict is the first by a U.S. jury to award damages over the claims.

Johnson & Johnson spokesperson Carol Goodrich says “we have no higher responsibility than the health and safety of consumers, and we are disappointed with the outcome of the trial. We sympathize with the plaintiff’s family but firmly believe the safety of cosmetic talc is supported by decades of scientific evidence.”

Valeant Pharmaceuticals International Inc now owns the Shower to Shower brand but was not a defendant in the Fox case.

Join Our Fan Club
Coverage Area
Downtown Toronto
96.7FM
Toronto HD
96.3 HD-2
Kingston to Windsor, Parry Sound to Pittsburgh
AM740
ZoomerRadio Logo

Recently Played: